Healthcare -
Biotechnology - NASDAQ - US
$ 12.73
-6.47 %
$ 1.44 B
Market Cap
-3.78
P/E
DYN - STOCK-BASED COMPENSATION
Stock-based Compensation DYN - Dyne Therapeutics, Inc.
20 M
LAST VALUE
6.70%
2 YEAR CAGR
624.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR